Xeris Biopharma Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Chicago, IL
XERS chart
What traders are saying about $XERS
Latest postsXeris Biopharma Holdings, Inc. news
- What Xeris Biopharma Holders Bought Into Before A 116% Run
Simply Wall St ·
- Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?
stocktwits.com ·
- Why Xeris Biopharma Holdings (XERS) Is Up 16.2% And What's Next
Yahoo Finance ·
- Is Xeris Biopharma Holdings (XERS) Overpriced After Its Q3 Beat And 2026 Outlook Raise?
Yahoo Finance ·
- Xeris Biopharma (XERS) Adds Menassie M. Taddese To Its Board
Yahoo Finance ·
- 24% Overvalued? Xeris Biopharma Holdings (XERS) Following Raised 2026 Guidance
Simply Wall St ·
- Xeris Biopharma Q3 Earnings Call Highlights
marketbeat.com ·
- Xeris Biopharma Holdings Inc (XERS) (Q3 2026) Earnings Call Highlights: Revenue Surges 44% as ...
Yahoo Finance ·
- Oppenheimer maintains Xeris Biopharma Holdings at Outperform, raises price target to $21 from $18
TradingView ·
- Can You Justify Buying Corcept Stock Today?
trefis.com ·
- Why Xeris Biopharma Holdings (XERS) Is Up 25.0% And What's Next
Simply Wall St ·
- Xeris Biopharma Holdings (NasdaqGS:XERS) Stock Forecast & Analyst Predictions
Simply Wall St ·
Xeris Biopharma Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $291.8M | $203.1M | $163.9M | $110.2M |
| Net income | $554,000 | -$54.8M | -$62.3M | -$94.7M |
| Diluted EPS | $0.00 | $-0.37 | $-0.45 | $-0.70 |
| Total assets (year end) | $383.5M | $323.1M | $322.6M | $344.5M |
| Cash and equivalents (year end) | $111.0M | $71.6M | $67.4M | $122.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Xeris Biopharma Holdings, Inc.
- Ticker
- XERS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chicago, IL
- Fiscal year end
- December 31
- SEC CIK
- 1867096
Frequently asked questions
What exchange is Xeris Biopharma Holdings, Inc. listed on?
Xeris Biopharma Holdings, Inc. trades on the Nasdaq under the ticker symbol XERS.
What industry is Xeris Biopharma Holdings, Inc. in?
Xeris Biopharma Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Xeris Biopharma Holdings, Inc. headquartered?
Xeris Biopharma Holdings, Inc.'s business address on file with the SEC is in Chicago, IL.
When does Xeris Biopharma Holdings, Inc.'s fiscal year end?
Xeris Biopharma Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Xeris Biopharma Holdings, Inc. report?
Xeris Biopharma Holdings, Inc. reported $291.8M in revenue for calendar year 2025, according to its SEC filings.